Met Life Investment Management, LLC Selecta Biosciences Inc Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 410 shares of SELB stock, worth $344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

410

Holding current value

$344

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	410 New	410 $0
Q3 2023 May 09, 2024	BUY	$1.02 - $1.23 $63,422 - $76,480	62,179 New	62,179 $65,000
Q2 2023 Apr 29, 2024	BUY	$1.04 - $1.4 $64,666 - $87,050	62,179 New	62,179 $69,000
Q2 2023 Aug 10, 2023	BUY	$1.04 - $1.4 $64,666 - $87,050	62,179 New	62,179 $69,000
Q1 2022 May 12, 2022	SELL	$1.23 - $3.31 $44,373 - $119,411	-36,076 Closed	0 $0
Q4 2021 May 17, 2024	BUY	$2.89 - $4.43 $56,661 - $86,854	19,606 Added 119.04%	36,076 $117,000
Q4 2021 Jun 21, 2023	BUY	$2.89 - $4.43 $104,259 - $159,816	36,076 New	36,076 $117,000
Q4 2021 Mar 22, 2023	BUY	$2.89 - $4.43 $56,661 - $86,854	19,606 Added 119.04%	36,076 $117,000
Q4 2021 Feb 15, 2022	BUY	$2.89 - $4.43 $56,661 - $86,854	19,606 Added 119.04%	36,076 $118,000
Q3 2021 May 17, 2024	SELL	$3.36 - $4.62 $66,165 - $90,977	-19,692 Reduced 54.45%	16,470 $68,000
Q3 2021 Jun 21, 2023	BUY	$3.36 - $4.62 $55,339 - $76,091	16,470 New	16,470 $68,000
Q3 2021 Mar 22, 2023	SELL	$3.36 - $4.62 $66,165 - $90,977	-19,692 Reduced 54.45%	16,470 $68,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $66,165 - $90,977	-19,692 Reduced 54.45%	16,470 $69,000
Q2 2021 May 17, 2024	BUY	$2.82 - $5.01 $101,976 - $181,171	36,162 New	36,162 $151,000
Q2 2021 Jun 21, 2023	BUY	$2.82 - $5.01 $101,976 - $181,171	36,162 New	36,162 $151,000
Q2 2021 Mar 22, 2023	BUY	$2.82 - $5.01 $1,266 - $2,249	449 Added 1.26%	36,162 $151,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $101,976 - $181,171	36,162 New	36,162 $151,000
Q3 2020 Nov 13, 2020	SELL	$2.18 - $2.84 $77,854 - $101,424	-35,713 Closed	0 $0
Q2 2020 May 24, 2024	BUY	$1.83 - $4.06 $65,354 - $144,994	35,713 New	35,713 $101 Million
Q2 2020 Jun 26, 2023	BUY	$1.83 - $4.06 $65,354 - $144,994	35,713 New	35,713 $101,000
Q2 2020 Mar 22, 2023	BUY	$1.83 - $4.06 $38,821 - $86,128	21,214 Added 146.31%	35,713 $101,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $65,354 - $144,994	35,713 New	35,713 $101,000
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $38,567 - $230,969	-14,499 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$12.07 - $16.0 $111,768 - $148,160	9,260 New	9,260 $143,000
Q3 2018 Mar 22, 2023	BUY	$12.07 - $16.0 $175,002 - $231,984	14,499 New	14,499 $225,000
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $175,002 - $231,984	14,499 New	14,499 $225,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Selecta Biosciences Inc Transaction History